| Literature DB >> 35186787 |
Yuwei Zhang1, Liang Ren1, Qi Wang2, Zhining Wen3, Chengcheng Liu1, Yi Ding1.
Abstract
Oral diseases impose a major health burden worldwide and have a profound effect on general health. Dental caries, periodontal diseases, and oral cancers are the most common oral health conditions. Their occurrence and development are related to oral microbes, and effective measures for their prevention and the promotion of oral health are urgently needed. Raman spectroscopy detects molecular vibration information by collecting inelastic scattering light, allowing a "fingerprint" of a sample to be acquired. It provides the advantages of rapid, sensitive, accurate, and minimally invasive detection as well as minimal interference from water in the "fingerprint region." Owing to these characteristics, Raman spectroscopy has been used in medical detection in various fields to assist diagnosis and evaluate prognosis, such as detecting and differentiating between bacteria or between neoplastic and normal brain tissues. Many oral diseases are related to oral microbial dysbiosis, and their lesions differ from normal tissues in essential components. The colonization of keystone pathogens, such as Porphyromonas gingivalis, resulting in microbial dysbiosis in subgingival plaque, is the main cause of periodontitis. Moreover, the components in gingival crevicular fluid, such as infiltrating inflammatory cells and tissue degradation products, are markedly different between individuals with and without periodontitis. Regarding dental caries, the compositions of decayed teeth are transformed, accompanied by an increase in acid-producing bacteria. In oral cancers, the compositions and structures of lesions and normal tissues are different. Thus, the changes in bacteria and the components of saliva and tissue can be used in examinations as special markers for these oral diseases, and Raman spectroscopy has been acknowledged as a promising measure for detecting these markers. This review summarizes and discusses key research and remaining problems in this area. Based on this, suggestions for further study are proposed.Entities:
Keywords: Raman spectroscopy; dental caries; oral cancer; oral microbiota; periodontitis
Mesh:
Year: 2022 PMID: 35186787 PMCID: PMC8855094 DOI: 10.3389/fcimb.2022.775236
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Summary of RS studies on dental caries.
| Sample type | Target | Year | Authors | Raman shift | Meaning of the corresponding Raman shift | |
|---|---|---|---|---|---|---|
| Detecting early caries, verifying demineralization models, and testing accuracy of other tools | ||||||
| Dentin | Verifying intact and decayed dentin | 2018 | ( | 1665 cm–1; 1453 cm–1; 1270 cm–1; 961 cm–1 | Amide I; CH group; Amide III; Phosphate apatite | |
| Enamel | Verifying demineralized enamel | 2017 | ( | ~960 cm–1 | Phosphate apatite | |
| Teeth | Detecting caries | 2014 | ( | – | – | |
| Teeth | Verifying decayed teeth | 2013 | ( | ~575 cm–1; ~960 cm–1; ~1450 cm–1 | Fluoridated apatite; Phosphate apatite; Organic matrix | |
| Evaluating the remineralization of dental caries | ||||||
| Dentin | Remineralization effect of zinc-containing amalgam restoration | 2019 | ( | – | Organic and inorganic components | |
| Enamel | Remineralization of carious enamel | 2016 | ( | 960 cm–1 | Phosphate apatite | |
| Dentin | Remineralization effect of self-etching zinc-doped adhesives | 2015 | ( | – | Organic and inorganic components | |
| Dentin | Remineralization effect of zinc-containing amalgam loads | 2015 | ( | – | Organic and inorganic components | |
| Enamel | Remineralization effect of PAA-BAG and BAG on WSL | 2014 | ( | 433 cm–1; 579 cm–1; 959 cm–1; 1043 cm–1 | Phosphate apatite | |
| Distinguishing intact, infected, and affected dentin to define the margin of defective dentin precisely | ||||||
| Dentin | Combining fluorescence spectra with Raman spectra | 2012 | ( | 960 cm –1; 1340 cm –1 | Phosphate; Protein α-helices | |
| Exploring the effects of radiation therapy on tooth components | ||||||
| Dentin | Inorganic components | 2019 | ( | 590 cm–1; 1070 cm–1; 1267 cm–1 | Fluoridated apatite; Phosphate apatite; | |
| Teeth | Mineral composition; Collagen changes | 2019 | ( | 1070 cm–1/960 cm–1; 1655 or 1667 cm–1/1246 or 1270 cm–1; 1655 or 1667 cm–1/1450 cm–1; | Carbonate/Mineral; Amide I/Amide III; Amide I/CH2 | |
| Teeth | Ratio of organic to inorganic components | 2019 | ( | 2931/960 cm–1 | Protein/Mineral | |
| Evaluating new bonding systems | ||||||
| Adhesive | Ratio of uncured to cured unit | 2019 | ( | 1639 or 1640 cm–1; | Aliphatic C=C stretching; Aromatic C=C stretching | |
| 2019 | ( | |||||
| Exploring the effect of quaternary ammonium salts (QAS) on cariogenic biofilms | ||||||
| Biofilm | Effect of QAS on cariogenic biofilm changes | 2020 | ( | 484 cm–1; 960 cm–1; 430 cm–1; 1070 cm–1 | Polysaccharide; Phosphate; Carbonate | |
| 2019 | ( | |||||
| Biofilm | Metabolism of different biofilms | 2020 | ( | – | – | |
| Single cell of bacteria | Metabolic changes of single cell of bacteria after exposure to drugs | 2020 | ( | 2040–2300 cm–1 | C–D vibration | |
WSL, white spot lesion; QAS, quaternary ammonium salts.
Summary of RS studies on periodontal disease.
| Sample type | Target | Year | Authors | Raman shift | Meaning of the corresponding Raman shift |
|---|---|---|---|---|---|
| Assisting diagnosis and detection of inflammatory factors and composition changes | |||||
| Periodontal ligament | Protein secondary structure | 2020 | ( | 1307 cm−1; 1230–1250 cm−1; 1240–1270 cm−1; 1620 cm−1; 1668 cm−1; 1680 cm−1;2930 cm−1; 2875 cm−1; 2970 cm−1 | α-helix; β-sheet; random coil; β-sheet or collagen 310-helix, β-turn and β-sheet secondary structure; CH3 and CH2 |
| Saliva | IL-1β; TNF-α | 2020 | ( | 1335 cm–1; 1590 cm–1 | DTNB; 4-MBA |
| Saliva | Sialic acid | 2019 | ( | 1002 cm–1, 1237 cm–1, and 1391 cm–1; OR 910 cm–1, 1171 cm–1, and 1360 cm–1 | Sialic acid |
| GCF | Mineral–matrix ratio; Carbonate apatite–hydroxyapatite ratio; | 2014 | ( | 984 cm−1/1667 cm−1; 1088 cm−1/984 cm−1; | Phosphate/Amide I; Carbonate/Phosphate; |
| Saliva | Carotenoids | 2011 | ( | 1155 cm–1; 1525 cm–1 | C–C; C=C |
| Detecting metabolites of periodontal bacteria | |||||
|
| – | 2016 | ( | – | – |
|
| Heme pigment | 2003 | ( | 338 cm–1; 370 cm–1; 1549 cm–1; 1570 cm–1; 1580 cm–1; 1618 cm–1; 1621 cm–1 | – |
| Distinguish subgingival bacteria | |||||
|
| – | 2021 | ( | – | – |
|
| – | 2020 | ( | – | – |
Summary of RS studies on oral cancer.
| Sample type | Sample numbers | Year | Authors | RS (spectral region; laser used) | Data analysis methodology |
|---|---|---|---|---|---|
| Clarifying tumor stage, histological classification and cancer subtype | |||||
| Tumor resection specimen | OSCC = 20; VC = 4; OLK = 5; N = 8 | 2019 | ( | SERS; 500–1800 cm–1; 488 nm | PCA-DA |
| Serum | Buccal cancer = 40; Tongue cancer = 50; Floor of mouth cancer = 45 | 2018 | ( | SERS; 200–1800 cm–1; 633 nm | PCA-LDA; LOOCV |
| Tissue engineering models | Models = 27: N (NOF; NOK); Dysplastic (DOK; D19; D20); HNC (Cal27; SCC4; FaDu) | 2017 | ( | 600–1800 cm–1 and 2800–3400 cm–1; 532 nm | PCA-LDA; CA |
| Buccal pouch tissue |
| 2015 | ( | 1200–1800 cm–1;785 nm | PCA; PCA-LDA |
| Cells | Radioresistant cell sublines (70Gy-UPCI : SCC029B; 50Gy-UPCI : SCC029B); | 2014 | ( | 900–1800 cm–1; 785 nm | PCA |
| Differentiating diagnosis between normal, precancerous lesions and cancer | |||||
| Tumor resection specimen | OSCC = 20; VC = 4; OLK = 5; N = 8 | 2019 | ( | SERS (catheter (5–6 µm)); 500–1800 cm–1; 488 nm | PCA-DA |
| Tissue engineering models | Models = 27: N (NOF; NOK); Dysplastic cells (DOK; D19; D20); HNC (Cal27; SCC4; FaDu) | 2017 | ( | 600–1800 cm–1 and 2800–3400 cm–1 | PCA-LDA; CA |
|
| OSCC = 113; OSMF = 25; OLK = 33; | 2014 | ( | 900–1750 cm–1; 785 nm | PCA-LDA |
| Differentiating diagnosis between different tumors (OSCC, other oral tumors and carcinomas in other systems) | |||||
| Serum | HV = 39; Breast cancer = 42; Colorectal cancer = 109; Lung cancer = 33; Oral cancer = 17; Ovarian cancer = 13 | 2019 | ( | SERS; 600–1800 cm–1; 532 nm | PCA-LDA |
| Tissue frozen section | OSCC = 20; VC = 4; OLK = 5; N = 8 | 2019 | ( | SERS(catheter (5–6 µm)); 500–1800 cm–1; 488 nm | PCA-DA |
| Exfoliated cell | N = 13; OLK = 13; OSCC = 10 | 2019 | ( | 200–2000 cm–1; 785 nm | PCA-LDA; k-fold cross-validation |
| Exfoliated cell | Tumor = 16; Contralateral mucosa = 16; HT = 20 | 2019 | ( | 800–1800 cm–1; 785 nm | PCA-LDA; LOOCV |
| Exfoliated cell | HV = 20; TH = 20; OPL = 27 | 2017 | ( | 800–1800 cm–1; 785 nm | PCA-LDA |
| Serum | OSCC = 135; MEC = 90; HV = 145 | 2017 | ( | SERS; Fingerprint regions (200–1800 cm–1); 633 nm | PCA-LDA |
| Saliva and exfoliated cell | Person: HV = 18; OSCC = 18; Spectra: Saliva = 180; Cell = 120 | 2016 | ( | SERS; 800–1800 cm–1; 785 nm | PCA-LDA; PCA-LR |
| Serum | PA = 20; WT = 21; MEC = 19; HV = 31 | 2015 | ( | SERS; 200–1800 cm–1; 633 nm | SVM |
| Tissue section | HV = 20; PA = 20; WT = 20 | 2011 | ( | 800–1800 cm–1; 785 nm | SVM |
| Obtaining more important information to elevate differentiation efficacy | |||||
| Exfoliated cell | N = 13; OLK = 13; OSCC = 10; | 2019 | ( | 200–2000 cm–1; 785 nm | PCA-LDA; k-fold cross-validation |
| Cells | Nucleolus, nucleus and cytoplasm: SCC-4 = 60; DOK = 60; N = 60 | 2017 | ( | 2800–3600 cm–1; 532 nm | PCA-FDA |
| Dehydrated cancer cell | – | 2013 | ( | SERS; 400–2000 cm–1; 532 nm | – |
| Selecting better analysis methods to elevate differentiation efficacy | |||||
| Tissue section | N = 36; Tumor = 44 (tongue, buccal mucosa, gingiva) | 2019 | ( | 700–2000 cm–1; 532 nm | PCA-LDA; PCA-QDA; LOOCV; k-fold cross-validation |
| Tumor resection specimen | OSCC = 14; N = 11 | 2016 | ( | 400–1800 cm–1; 785 nm | PCA-(h)LDA |
| Focusing on biomarkers to elevate differentiation efficacy | |||||
| Saliva | OSCC = 6; HV = 5 | 2020 | ( | SERS; 600–1720 cm–1; 785 nm | PCA |
| Saliva | OSCC = 3; Lymphoma = 1; Actinomyces infection = 1; HV = 3 | 2020 | ( | 100–3200 cm–1; 785 nm | PCA-LDA |
| Saliva | Oral dysplasia = 10; HV = 10 | 2020 | ( | SERS; - | – |
| Saliva | OSCC = 3; HV = 3 | 2019 | ( | SERS; 1100–1700 cm–1; 638 nm | Mann–Whitney U-test |
| Tissue section | OSCC = 13; N = 11 | 2016 | ( | 800–1800 cm–1; 488 nm | Multivariate curve resolution with alternating least squares |
| Assessing surgical margins | |||||
| Tissue resection specimen | OSCC (mandibular bone) = 20 | 2018 | ( | 2500–4000 cm–1; 671 nm | PCA-LDA; Mann–Whitney U-test; ROC |
| Tumor resection specimen | OSCC (tongue) = 20 | 2016 | ( | 2500–4000 cm–1; 671 nm | Mann–Whitney U-test |
| Tumor resection specimen | OSCC = 14; N =11 | 2016 | ( | 400–1800 cm–1; 785 nm | PCA-(h)LDA |
| Tumor resection specimen | OSCC (tongue) = 14 | 2015 | ( | 2500–4000 cm–1; 671 nm | Mann–Whitney U-test; ROC |
| Predicting oral cancer recurrence | |||||
| Exfoliated cell | Tumor = 16; Contralateral mucosa = 16; HT = 20 | 2019 | ( | 800–1800 cm–1; 785 nm | PCA-LDA; LOOCV |
|
| Tumor and contralateral normal mucosa = 99 | 2017 | ( | 785 nm | PCA-LDA; LOOCV |
| Serum | Recurrence = 10; No-recurrence = 12 | 2015 | ( | 700–1800 cm–1; 785 nm | PCA-LDA; LOOCV |
OSCC, oral squamous cell carcinoma; N, normal; HV, healthy volunteers; TH, tobacco habit; OPL, oral premalignant conditions; HNC, head and neck cancer; VC, verrucous carcinoma; OSMF, oral submucous fibrosis; OLK, leukoplakia; MEC, mucoepidermoid carcinoma; PA, pleomorphic adenoma; WT, Warthin’s tumor.